ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Fermenta Biotech reported H1FY27 consolidated revenue of Rs. 261.9 Crore, a 7% YoY decline. Profit after tax fell 52% to Rs. 18.9 Crore, impacted by lower animal nutrition pricing.
Fermenta Biotech Limited's board has approved the closure of its inactive wholly-owned subsidiary, Fermenta Biotech (UK) Limited. The move aims to reorganize corporate structure and reduce compliance costs following the UK's exit from the EU.
Fermenta Biotech Ltd reported revenue from operations of ₹132.7 Cr (+1.9% YoY) and net profit of ₹9.4 Cr (-47.8% YoY) for Q2 FY27.
Fermenta Biotech schedules a board meeting on November 5, 2026 to approve unaudited quarterly and half-year results. The trading window stays closed until 48 hours after results.
Fermenta Biotech Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Fermenta Biotech Limited promoter Preeti Thakkar sold 11,65,938 equity shares (3.96%) in the open market. Her shareholding decreased from 7.61% to 3.65% following the transaction.
Fermenta Biotech Ltd promoter Preeti Thakkar sold 11,65,938 equity shares via open market sale. The transaction valued at ₹55.34 Crore reduced her stake from 7.61% to 3.65%.
KMP Sumesh Gandhi sold a total of 3,900 equity shares in three separate market transactions on September 7, 8, and 9, 2026.
Fermenta Biotech Limited signed an exclusive licence agreement with VIT Vellore to commercialize Vitamin B12 fortification technology for fermented foods, enhancing its product portfolio.
Director Prashant Nagre sold 44,000 shares of Fermenta Biotech Ltd via market sale. The transaction value is Rs.2.20 Crore.
Fermenta Biotech Limited received a credit rating upgrade from CARE Ratings. Long-term bank facilities were raised to 'CARE BBB+; Stable' and short-term to 'CARE A2'.